251 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 28209920 | Effect of captopril on radiation-induced TGF-β1 secretion in EA.Hy926 human umbilical vein endothelial cells. | 2017 Mar 28 | 1 |
2 | 28878298 | Upregulation of cathepsin C expression contributes to endothelial chymase activation in preeclampsia. | 2017 Dec | 2 |
3 | 26612192 | Serum levels of renin, angiotensin-converting enzyme and angiotensin II in patients treated by surgical excision, propranolol and captopril for problematic proliferating infantile haemangioma. | 2016 Mar | 1 |
4 | 24138103 | Effects of neutral endopeptidase (neprilysin) inhibition on the response to other vasoactive peptides in small human resistance arteries: studies with thiorphan and omapatrilat. | 2014 Feb | 2 |
5 | 25401104 | Activation of the AT1R/HIF-1 α /ACE axis mediates angiotensin II-induced VEGF synthesis in mesenchymal stem cells. | 2014 | 1 |
6 | 24552291 | A novel design of combining the angiotensin converting enzyme (ACE) inhibitor captopril with the angiotensin receptor blocker (ARB) losartan using homo coupling via PEG diacid linker. | 2013 Dec | 2 |
7 | 22539586 | Vitamin D3 therapy corrects the tissue sensitivity to angiotensin ii akin to the action of a converting enzyme inhibitor in obese hypertensives: an interventional study. | 2012 Jul | 2 |
8 | 22002336 | Renal responses to three types of renin-angiotensin system blockers in patients with diabetes mellitus on a high-salt diet: a need for higher doses in diabetic patients? | 2011 Dec | 1 |
9 | 20035777 | FURO/CAP: a protocol for sodium intake sensitization. | 2010 Mar 30 | 3 |
10 | 20216091 | A mechanism for salt-sensitive hypertension: abnormal dietary sodium-mediated vascular response to angiotensin-II. | 2010 May | 1 |
11 | 22371796 | Renal vascular response to angiotensin II inhibition in intensive antihypertensive treatment of essential hypertension. | 2010 Aug 30 | 1 |
12 | 19712706 | Inhibition of intracellular angiotensin II formation blocks high glucose effect on mesangial matrix. | 2009 Nov 27 | 2 |
13 | 18551010 | Angiotensinogen genotype predicts abnormal renal hemodynamics in young hypertensive patients. | 2008 Jul | 2 |
14 | 17027145 | Positive feedback of hepatic angiotensinogen expression in silver sea bream (Sparus sarba). | 2007 Jan 15 | 1 |
15 | 17481528 | Antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor blockers in pancreatic ductal adenocarcinoma. | 2007 May | 2 |
16 | 17004021 | The effect of sublingual captopril versus intravenous enalaprilat on angiotensin II plasma levels. | 2006 Jun | 3 |
17 | 17044667 | A case of Gitelman's syndrome with decreased angiotensin II-forming activity. | 2006 Jul | 1 |
18 | 12588767 | ACE-versus chymase-dependent angiotensin II generation in human coronary arteries: a matter of efficiency? | 2003 Feb 1 | 1 |
19 | 14530469 | Reliability of captopril renography in patients under chronic therapy with angiotensin II (AT1) receptor antagonists. | 2003 Oct | 1 |
20 | 12140730 | AT(1)-receptor blockade and the kidney: importance of non-ACE pathways in health and disease. | 2002 Aug | 1 |
21 | 12179974 | Separation and detection of angiotensin peptides by Cu(II) complexation and capillary electrophoresis with UV and electrochemical detection. | 2002 Jun | 2 |
22 | 11260405 | Renal vascular responses to captopril and to candesartan in patients with type 1 diabetes mellitus. | 2001 Apr | 1 |
23 | 10741903 | Angiotensin converting-like enzymes from urine of untreated renovascular hypertensive and normal patients: purification and characterization. | 2000 Mar | 1 |
24 | 10755201 | Angiotensin II formation in human vasculature after chronic ACE inhibition: a prospective, randomized, placebo-controlled study. QUO VADIS Investigators. | 2000 Feb | 1 |
25 | 10805521 | Coumarin-Ser-Asp-Lys-Pro-OH, a fluorescent substrate for determination of angiotensin-converting enzyme activity via high-performance liquid chromatography. | 2000 Apr 10 | 1 |
26 | 10904023 | Effect of angiotensin II antagonist eprosartan on hyperglycemia-induced activation of intrarenal renin-angiotensin system in healthy humans. | 2000 Jul | 2 |
27 | 10933362 | High dose angiotensin-converting enzyme inhibition prevents fluid volume expansion in heart transplant recipients. | 2000 Aug | 1 |
28 | 10953996 | Insulin and insulin-like growth factor-I promotes angiotensinogen production and growth in vascular smooth muscle cells. | 2000 Aug | 1 |
29 | 11967825 | Should the use of short acting angiotensin-converting enzyme inhibitors be abandoned? | 2000 Dec | 1 |
30 | 9951431 | Inhibition of angiotensin-converting enzyme in human hand veins. | 1999 Jan | 1 |
31 | 10397679 | Angiotensin induces inflammatory activation of human vascular smooth muscle cells. | 1999 Jul | 2 |
32 | 10583422 | Angiotensin II increases erythropoietin production in healthy human volunteers. | 1999 Oct | 1 |
33 | 10594341 | Nitric oxide modulates captopril-mediated angiotensin-converting enzyme inhibition in porcine iliac arteries. | 1999 Nov 26 | 2 |
34 | 10604545 | Specific direct radioimmunoassay of angiotensin II (AT II) in human plasma and the effect of angiotensin converting enzyme (ACE) inhibitor. | 1999 Oct 15 | 3 |
35 | 10937954 | Neurohormonal reactivation in heart failure patients on chronic ACE inhibitor therapy: a longitudinal study. | 1999 Dec | 3 |
36 | 27093744 | SHORT-TERM EFFECT OF CAPTOPRIL ON INTRAOCULAR PRESSURE. | 1999 Jan | 1 |
37 | 9426022 | Long-term nitroglycerin treatment is associated with supersensitivity to vasoconstrictors in men with stable coronary artery disease: prevention by concomitant treatment with captopril. | 1998 Jan | 2 |
38 | 9562290 | Effect of exercise-induced acidosis on aldosterone secretion in men. | 1998 Apr | 1 |
39 | 9585459 | The Effects of Sublingual Administration of Captopril on Parameters of Exercise Test and Neurohormonal Activation in Patients With Stable Angina Pectoris | 1998 May | 1 |
40 | 9846641 | Dual pathway for angiotensin II formation in human internal mammary arteries. | 1998 Nov | 3 |
41 | 9116923 | Captopril does not blunt the sympathoadrenal response to cigarette smoking in normotensive humans. | 1997 Jan | 1 |
42 | 9187274 | Substrate dependence of angiotensin I-converting enzyme inhibition: captopril displays a partial selectivity for inhibition of N-acetyl-seryl-aspartyl-lysyl-proline hydrolysis compared with that of angiotensin I. | 1997 Jun | 3 |
43 | 8613260 | Angiotensin mediates forearm glucose uptake by hemodynamic rather than direct effects. | 1996 Apr | 2 |
44 | 8768914 | Captopril and renal survival in patients with human immunodeficiency virus nephropathy. | 1996 Aug | 1 |
45 | 8793704 | Effects of captopril related to increased levels of prostacyclin and angiotensin-(1-7) in essential hypertension. | 1996 Jun | 1 |
46 | 8936398 | Enhanced psychophysiological signs of attention after angiotensin-converting enzyme inhibition by captopril. | 1996 May | 1 |
47 | 8967354 | Analysis of responses to angiotensin I-(3-10) in the hindlimb vascular bed of the cat. | 1996 Apr | 1 |
48 | 8971427 | Effect of captopril on prostacyclin and nitric oxide formation in healthy human subjects: interaction with low dose acetylsalicylic acid. | 1996 Dec | 1 |
49 | 7609934 | Predictive value of captopril transit renography in essential hypertension and diabetic nephropathy. | 1995 Jan | 1 |
50 | 7611494 | Analysis of responses to angiotensin peptides in the hindquarters vascular bed of the cat. | 1995 Jun | 2 |